This past Friday, the Northwest Biotherapeutics (OTCMKTS:NWBO) stock recorded gains of 14%, and this morning it has carried on in the same vein, having clocked gains of 15% already.
There has been no fresh development this morning with regards to Northwest but the rally is possibly linked to its application to the Medicines and Healthcare Products Regulatory Agency (MHRA) for certification of its manufacturing plant in Sawston, United Kingdom. It also emerged that the actual application package for the same had been submitted to the MHRA back on May 7.
The company has prepared for this application for as long as two years and a major part of that had been conducted during the coronavirus pandemic. Northwest completed the physical build-out of the plant, prepared as many as 500 documents meant for the regulatory authorities, and also created a team of 40 professionals who possess the skills associated with Advanced Therapy Medicinal Products.
Biotech, Tech, and Crypto reporter
Anthony Gonzales brings 3 years of experience in helping grassroots, mid-sized organizations and large institutions strengthen their management and resource generating capacities and effectively plan for the future. He is also a mentor and professional advisor to artists working in all disciplines. He is the gold medalist from St. Marco University of Science and Technology in the Bachelors of Financial Management as well.